27.01.2011
- Sanofi-Aventis has made progress in talks with U.S. bid target Genzyme and leaders of both companies may bump into each other in Davos this week, Sanofi's CEO said on Wednesday...
24.01.2011
- French drugmaker Sanofi-Aventis extended its snubbed $18.5 billion tender offer for U.S. biotech Genzyme for a second time as the companies continue behind-the-scenes talks to...
20.01.2011
- French drugmaker Sanofi-Aventis is likely to extend its $18.5 billion tender offer for Genzyme one last time as it seeks to buy the U.S. maker of drugs for rare diseases, sources...
19.01.2011
- German companies have started to prop up their defenses to avoid becoming easy prey for possible suitors in the wake of Spanish builder ACS's pursuit of Hochtief, a top investment...
18.01.2011
- EU regulators said on Monday they were pressing pharmaceutical companies for more information on their patent deals with generic companies to make sure there is no delay in cheaper...
14.01.2011
- French drugmaker Sanofi-Aventis hopes to reach a takeover deal that would value U.S. target Genzyme at around $76 per share, or some $20 billion, the French daily newspaper Le...
14.01.2011
- Bristol-Myers Squibb said it has recalled 64 million tablets of the blood pressure medicine Avalide in the United States and Puerto Rico due to the potential for reduced...
13.01.2011
- French drugmaker Sanofi-Aventis won European Union regulatory approval on Wednesday for its hostile $18.5 billion takeover bid for U.S. biotech firm Genzyme. The European...
